The authors designed a dissection method for validating the use of a 15-gene hypoxia classifier, which was previously established for head and neck squamous cell carcinoma patients, to identify hypoxia in prostate cancer.
[Cancers]
Sorry, but the selected Zotpress account can't be found.
